- Home
- SABS vs ABTS Comparison
SABS vs ABTS Comparison
Compare SABS & ABTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SABS
- ABTS
- Stock Information
- Founded
- SABS 2014
- ABTS 2010
- Country
- SABS United States
- ABTS Hong Kong
- Employees
- SABS N/A
- ABTS N/A
- Industry
- SABS Biotechnology: Pharmaceutical Preparations
- ABTS Computer Software: Programming Data Processing
- Sector
- SABS Health Care
- ABTS Technology
- Exchange
- SABS Nasdaq
- ABTS Nasdaq
- Market Cap
- SABS 19.0M
- ABTS 15.9M
- IPO Year
- SABS N/A
- ABTS N/A
- Fundamental
- Price
- SABS $1.25
- ABTS $2.53
- Analyst Decision
- SABS Strong Buy
- ABTS
- Analyst Count
- SABS 5
- ABTS 0
- Target Price
- SABS $11.40
- ABTS N/A
- AVG Volume (30 Days)
- SABS 38.1K
- ABTS 21.7K
- Earning Date
- SABS 05-19-2025
- ABTS 12-31-2024
- Dividend Yield
- SABS N/A
- ABTS N/A
- EPS Growth
- SABS N/A
- ABTS N/A
- EPS
- SABS N/A
- ABTS N/A
- Revenue
- SABS $1,322,410.00
- ABTS $5,343,888.00
- Revenue This Year
- SABS N/A
- ABTS N/A
- Revenue Next Year
- SABS $25.00
- ABTS N/A
- P/E Ratio
- SABS N/A
- ABTS N/A
- Revenue Growth
- SABS N/A
- ABTS 3970.66
- 52 Week Low
- SABS $1.11
- ABTS $0.25
- 52 Week High
- SABS $5.01
- ABTS $4.19
- Technical
- Relative Strength Index (RSI)
- SABS 31.17
- ABTS 51.02
- Support Level
- SABS $1.11
- ABTS $2.92
- Resistance Level
- SABS $1.80
- ABTS $3.28
- Average True Range (ATR)
- SABS 0.16
- ABTS 0.30
- MACD
- SABS -0.01
- ABTS -0.17
- Stochastic Oscillator
- SABS 18.42
- ABTS 11.62
About SABS SAB Biotherapeutics Inc.
SAB Biotherapeutics Inc is a clinical stage biopharmaceutical company focused on the development and commercialization of a portfolio of products from its proprietary immunotherapy platform to produce fully targeted human polyclonal antibodies, without using human plasma or serum. The company's novel DiversitAb platform enables the rapid production of large amounts of targeted human polyclonal antibodies, leveraging transchromosomic cattle (Tc Bovine) that have been genetically designed to produce human antibodies (immunoglobulin G) rather than bovine in response to an antigen. Animal antibodies have been made in rabbits, sheep and horses.
About ABTS Abits Group Inc
Abits Group Inc is a digital data center operator with bitcoin self-mining operations.